This episode of "This Week in Virology" delves into the intersection of science, public health, and misinformation, beginning with a detailed refutation of the politically charged claim linking acetaminophen use during pregnancy to autism. The hosts analyze the scientific literature, highlighting the lack of robust evidence and the significant impact of confounding factors.
The scientific discussions feature two main papers. The first, from Nature Communications, explores the genetic engineering of chickens to resist avian influenza by editing the ANP32A host protein. While initial results were promising, the virus quickly developed escape mutations, suggesting that a more complex, multi-gene editing approach would be necessary for complete resistance. The second paper, from Cell, details the creation of a humanized mouse model for HTLV-1 infection. This model was used to test therapeutic strategies, revealing that a combination of antiretrovirals and an MCL1 inhibitor (a drug that promotes apoptosis in infected cells) can effectively mitigate the infection, paving the way for potential new treatments. The episode concludes with listener emails and the hosts' "picks of the week."
TWiV 1257: Crisper Chickens, HTLV-1 Therapies, and Scientific Sense
00:03:48 Debunking the Acetaminophen-Autism Link: The hosts address recent political claims linking acetaminophen (Tylenol/Paracetamol) use during pregnancy to autism. They explain that robust, well-controlled scientific studies do not support this link. Key Takeaways:
Many studies finding a minor association are plagued by confounding factors, and the better the study's statistical design, the weaker the association becomes.
Experts agree the rising incidence of autism is primarily due to a broadened diagnostic definition, not an environmental cause.
Spreading this misinformation is harmful, as it places undue blame on mothers and may cause pregnant women to avoid necessary medication for fever and pain.
00:14:58 Paper 1: Engineering Flu-Resistant Chickens: The team discusses a study on creating avian influenza-resistant chickens using CRISPR to edit the host protein ANP32A, which the virus's polymerase requires to function.
00:27:32 Initial Success: Chickens with two amino acid changes in ANP32A showed significant resistance to infection and did not transmit the virus at a low infectious dose.
00:29:27 Viral Escape: At a higher dose, the virus was able to replicate in some of the modified chickens by evolving mutations in its own polymerase to overcome the host's resistance.
00:35:38 Future Directions: Deleting the entire ANP32A gene was insufficient, as the virus adapted to use other proteins in the same family (ANP32B and E). While deleting all three proteins in cell lines completely blocked replication, creating a viable chicken with a triple knockout is likely not possible.
00:46:34 Paper 2: A New Therapeutic Strategy for HTLV-1: The hosts review a paper detailing a novel humanized mouse model for Human T-lymphotropic Virus 1 (HTLV-1), a retrovirus that can cause leukemia and neurological disease.
00:53:34 Developing a Model: Researchers successfully created a humanized mouse model that recapitulates key features of HTLV-1 infection, including the expansion of infected CD4+ T-cells and proviral characteristics seen in human patients.
01:03:05 Testing Antiretrovirals: Standard anti-HIV drugs like Tenofovir and Dolutegravir showed some efficacy in reducing viral spread in the model, particularly when used in combination as a post-exposure therapy.
01:06:01 Targeting Apoptosis: The virus prevents infected cells from dying by upregulating the anti-apoptosis protein MCL1. A combination therapy of antiretrovirals plus a novel MCL1 inhibitor was highly effective, eliminating detectable proviruses in over 80% of the treated mice. This suggests a powerful new therapeutic avenue for HTLV-1.
01:13:28 Listener Mail: The episode features several listener emails, including a personal story from a patient who received successful AAV-based gene therapy for hemophilia B nine years ago, and a critique of claims made by Jay Bhattacharya regarding mRNA vaccines.
Rich: An article in Emerging Infectious Diseases arguing that Chagas disease should be considered endemic in the United States.
Alan: A Science magazine article detailing the "long strange trip" of an invaluable archive of molecular biology history, including Rosalind Franklin's Photo 51, which is now available to the public.
Vincent: A Wired article titled "The World’s Oceans Are Hurtling Toward a Breaking Point," summarizing the cumulative pressures of climate change, pollution, and overfishing.